You Have a Great Story

Menlo Park, CA

Akoya Biosciences’ history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today’s Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.

Houston, TX

Alzeca is focused on developing novel targeted MRI imaging agents for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company’s proprietary technology is based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear.

Houston, TX
 

Aravive is a clinical stage biotechnology company focused on developing new therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.The company's primary therapeutics focus is the GAS6-AXL pathway, which can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread and acquire therapeutic resistance.

Farmington, CT

Azitra, Inc. is a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease.

Paris, France

Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.

Basking Ridge, NJ

Caladrius is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases.

Ann Arbor, MI

Celsee’s first product, the Genesis system, enables scientists to analyze and interpret cellular behavior and collect previously inaccessible information for improved results in applications such as proteogenomics, next-generation sequencing, immune monitoring, and cell therapy.

Orlando, FL

Hesperos has develops a tool to characterize an individual’s biology with human-on-a-chip microfluidic systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational modeling of live physiological responses of functional neurons, cardiac, muscle, and neuromuscular junctions as well as liver, pancreas and barrier tissues.

Boulder, CO

Inscripta is a gene-editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, forward cell-engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene-editing tools.

San Jose, CA

Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.

Austin, TX

Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.

Emeryville, CA

Founded by physicists from the University of California-Berkeley and Lawrence Berkeley National Laboratory, Nanōmix is developing the next generation of mobile, point-of-care medical diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. .

Boston, MA

NanoView provides direct from sample, label-free characterization of extracellular vesicles with no purification required. The platform will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment.

Madison, WI

Stemina markets its ASD diagnostics through its neurological disorders division, NeuroPointDX. Their metabolomics-based tool assists with the diagnosis of autism spectrum disorder and is also relevant to other neurological disorders that are notoriously difficult to diagnose and treat, including schizophrenia, depression, and anxiety.

Wellesley, Mass and Reston, VA

Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.

Menlo Park, CA

Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.

Redwood City, CA

Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.

Beverly, MA

Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.

Stamford, CT

Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics.

Grand Rapids, MI

Tetra Discovery Partners is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, traumatic brain injury, major depression and schizophrenia. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Santa Cruz, CA

Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.

Mountain View, CA

twoXAR leverages its AI-based computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships.

Allakos • Association for Molecular Pathology • Applied Biosystems • BD Biosciences • Benchling • Biotique Systems • Cellular Research • Chiron Corporation • Connetics • Cynvenio Biosystems • DNAnexus • DoubleTwist • Eos • Eurofins Genomics • Gen9 • GE healthymagination • Genentech • GenoSpectra • IntegenX • Invitrogen • Medcision • Microsoft Health Solutions • Medtronic • Mohr Davidow Ventures • NanoString Technologies • Nektar • Omicia • Osel • PAG • PaxVax • Personalis • Protagonist • RainDance Technologies • StationX • Varian Medical Systems • VitaPath Genetics • Zyomyx